Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorunjan Tablets for Acute Gouty Arthritis (Lime-like Mucus Type)
CTR20202704Phase 3Completed
- Sponsor
- Xinjiang Uygur Pharmaceutical Co., Ltd.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sorunjan in acute gout flare, sponsored by Xinjiang Uygur Pharmaceutical Co., Ltd.. Started Jan 2021; status: completed.
02
Drugs
Sorunjan
03
Conditions
acute gout flare
Beyond the preview
Go deeper on CTR20202704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202704.